What is the Selena Sledai score?
The SELENA-SLEDAI consists of 24 items (nine organ systems) that are scored based on presence at the time of visit or in the preceding 10 days. The scoring is additive across items, with a possible total score range of 0 to 105 (higher scores represent greater disease activity).
What is the difference between Sledai and Sledai-2K?
SLEDAI-2K was modified to allow the documentation of ongoing disease activity in the descriptors: rash, alopecia, mucosal ulcers, and proteinuria. Thus SLEDAI-2K includes the presence of any inflammatory rash, alopecia, or mucosal ulcers, and new, recurrent, or persistent proteinuria greater than 0.5 grams in 24 hours.
What is Sri 4 lupus?
Background The SRI(4) is a composite endpoint used in SLE clinical trials. A post-hoc analysis of two Phase III studies of belimumab1 showed that the achievement of an SRI(4) response at 52 weeks is associated with clinically meaningful benefits, irrespective of the treatment assignments.
What are the 11 criteria for lupus diagnosis?
What are the 11 signs of lupus?
- Butterfly-shaped rash.
- Raised red patches on your skin.
- You’re sensitive to light.
- Ulcers in your mouth or nose.
- Arthritis in two or more joints, plus swelling or tenderness.
- Inflammation in the lining of your heart or lungs.
- Seizures or other nerve problems.
- Too much protein in your urine.
Is discoid lupus an autoimmune disorder?
It is thought that discoid lupus is an autoimmune disease. This means that some of the proteins made by the body to fight infection (antibodies), mistakenly attack normal cells in our body. in discoid lupus it is the skin cells that are attacked by these antibodies.
What is Sledai 2K?
SLEDAI-2K was developed as a modification of SLEDAI in order to include persistent, active disease in those descriptors that had previously only considered new or recurrent occurrences. Specifically SLEDAI-2K allows persistent active disease in alopecia, mucous membrane ulcers, rash, and proteinuria to be scored.
What is lupus Bicla?
Background/Purpose: BICLA is a validated composite global measure of SLE disease activity that incorporates BILAG, an instrument that distinguishes between partial and complete improvement. BICLA was an endpoint in the phase 3 TULIP-1 and TULIP-2 trials of anifrolumab.
How is lupus measured?
Although the most effective instrument to measure SLE disease activity is still open to debate, there are several validated measures, including the Systemic Lupus Activity Measure (SLAM), SLEDAI, Lupus Activity Index (LAI), European Consensus Lupus Activity Measurement (ECLAM), and British Isles Lupus Activity Group ( …
